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TECHNICAL NOTES Open Access
Dark-blood late gadolinium enhancement
without additional magnetization
preparation
Robert J. Holtackers1,2* , Amedeo Chiribiri1, Torben Schneider3, David M. Higgins3 and René M. Botnar1,4
Abstract
Background: This study evaluates a novel dark-blood late gadolinium enhancement (LGE) cardiovascular magnetic
resonance imaging (CMR) method, without using additional magnetization preparation, and compares it to
conventional bright-blood LGE, for the detection of ischaemic myocardial scar. LGE is able to clearly depict
myocardial infarction and macroscopic scarring from viable myocardium. However, due to the bright signal of
adjacent left ventricular blood, the apparent volume of scar tissue can be significantly reduced, or even completely
obscured. In addition, blood pool signal can mimic scar tissue and lead to false positive observations. Simply nulling
the blood magnetization by choosing shorter inversion times, leads to a negative viable myocardium signal that
appears equally as bright as scar due to the magnitude image reconstruction. However, by combining blood
magnetization nulling with the extended grayscale range of phase-sensitive inversion-recovery (PSIR), a darker
blood signal can be achieved whilst a dark myocardium and bright scar signal is preserved.
Methods: LGE was performed in nine male patients (63 ± 11y) using a PSIR pulse sequence, with both conventional
viable myocardium nulling and left ventricular blood nulling, in a randomized order. Regions of interest were drawn in
the left ventricular blood, viable myocardium, and scar tissue, to assess contrast-to-noise ratios. Maximum scar
transmurality, scar size, circumferential scar angle, and a confidence score for scar detection and maximum transmurality
were also assessed. Bloch simulations were performed to simulate the magnetization levels of the left ventricular blood,
viable myocardium, and scar tissue.
Results: Average scar-to-blood contrast was significantly (p < 0.001) increased by 99% when nulling left ventricular
blood instead of viable myocardium, while scar-to-myocardium contrast was maintained. Nulling left ventricular blood
also led to significantly (p = 0.038) higher expert confidence in scar detection and maximum transmurality. No significant
changes were found in scar transmurality (p = 0.317), normalized scar size (p = 0.054), and circumferential scar angle
(p = 0.117).
Conclusions: Nulling left ventricular blood magnetization for PSIR LGE leads to improved scar-to-blood contrast and
increased expert confidence in scar detection and scar transmurality. As no additional magnetization preparation is used,
clinical application on current MR systems is readily available without the need for extensive optimizations, software
modifications, and/or additional training.
Keywords: Delayed enhancement, Late enhancement, Late gadolinium enhancement, Dark blood, Phase-sensitive
inversion-recovery, Myocardial infarction, Myocardial scar
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Background
In the past decade, cardiovascular disease death rates
have seen a strong decline, mainly due to cardiovascular
risk factor control intervention. However, approximately
one of every seven deaths in the United States is still
caused by coronary heart disease [1]. As survivors of
myocardial infarction face a substantially higher risk of
new cardiovascular events due to heart failure, accurate
diagnosis and guidance of treatment are crucial in these
patients. An accurate assessment of the extent and
transmurality of the irreversibly injured cardiac tissue
(scar tissue) is essential information in the identification
of patients at increased risk of future events and in the
selection of the best therapeutic approach. Even tiny re-
gions of scar tissue of only 2% of the mean left ventricu-
lar (LV) mass are linked with a sevenfold increase in
major cardiac events [2]. Transmurality of the affected
area is equally of great importance, as it plays a major
role in the prediction of the likelihood of regional func-
tional recovery after revascularization [3–6].
Late gadolinium enhancement (LGE) cardiovascular
magnetic resonance imaging (CMR) has been considered
the reference standard in the non-invasive assessment of
myocardial viability for almost two decades, as LGE is
able to clearly depict myocardial infarction and macro-
scopic scarring from viable myocardium. LGE is based
on an inversion-recovery (IR) pulse sequence that is per-
formed 10–20 min after the intravenous injection of a
gadolinium-based contrast agent. This pulse sequence is
highly T1-weighted and therefore sensitive for detecting
the local effects of high concentrations of gadolinium.
The pulse sequence consists of a 180° inversion pulse,
followed by a delay time (called inversion time or TI),
and finally signal acquisition. The duration of the TI can
be adjusted to minimize or even null the magnetization,
which is routinely used in clinical practice to eliminate
signal from viable myocardium. However, due to the
bright signal of adjacent LV blood, the border between
scar and blood can be difficult to identify and the apparent
volume of scar tissue can be significantly reduced, or even
completely obscured. Obscuration particularly occurs in
cases of thin subendocardial scarring, mostly caused by
coronary artery disease and subsequent myocardial infarc-
tion. In addition, blood pool signal can mimic scar tissue
and lead to false positive observations. Simply shortening
the TI to null the LV blood magnetization not only results
in a negative signal of the viable myocardium, which ap-
pears equally as bright as scar due to the magnitude image
reconstruction, but also leads to significantly smaller scar
size [7, 8]. Furthermore, heart rate variations during ac-
quisition often result in suboptimal TIs for tissue nulling
and image artefacts.
These problems can be mitigated using phase-sensitive
inversion-recovery (PSIR). PSIR is commonly used for
LGE image acquisition as it avoids the need for precise
selection of the TI to null viable myocardium [7]. Com-
pared to a conventional IR sequence, the PSIR sequence
only applies a 180° inversion pulse once every two heart-
beats and a small-flip-angle reference acquisition is per-
formed during the second heartbeat. This reference
acquisition is used to accurately determine the phase of the
measured signal, acquired during the first heartbeat. The
PSIR sequence is therefore able to distinguish between
positive and negative longitudinal magnetization and will
represent the recovered longitudinal magnetization (Mz)
differently in the (corrected real) image produced for clin-
ical assessment: negative Mz appears darkest, nulled tissue
appears mid-gray, and positive Mz appears bright; whereas
in a traditional magnitude image nulled tissue appears
darkest and both negative and positive Mz appear bright
(Fig. 1). PSIR is routinely used in combination with nulling
of the viable myocardium magnetization, and the clinical
observer may adjust window levels to further darken viable
myocardial tissue, mimicking a magnitude image represen-
tation while maintaining the benefits of PSIR.
We propose a PSIR-specific TI optimization that instead
nulls blood and thus significantly improves scar-to-blood
contrast while maintaining the scar-to-myocardium con-
trast. As no additional magnetization preparation is used,
clinical application is readily available on current MR
systems without the need for extensive optimizations, soft-
ware modifications, and/or additional training.
PSIR’s extended grayscale range provides an opportunity
to achieve a darker blood signal whilst preserving bright
scar and dark myocardium signal. Setting a shorter TI,
such that the LV blood magnetization is close to the null
point of recovery, leads to a darker-gray appearance of the
LV blood in the PSIR image. The negative magnetization
from viable myocardium, that would appear bright in a
magnitude image, now appears completely black, as PSIR
reveals its negative phase. The positive scar magnetization
still appears bright due to its fast recovery, leading to an
increased dynamic contrast range and therefore offering
excellent contrast between areas of scar and both LV
blood and viable myocardium (Fig. 1c).
Methods
Study population
Patients enrolled for a clinical LGE MRI examination at
the St. Thomas Hospital in London (Guy’s and St
Thomas’ NHS Trust) were eligible to participate if they
were >18 years of age and agreed to 15 min of additional
MR imaging after the clinical protocol. Only patients
showing ischemic myocardial scar on the clinical images
were included and underwent additional MR imaging.
Patients unable to hold their breath or with poor vector-
cardiogram signal detection during the additional im-
aging were excluded from analysis. Participants provided
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written informed consent for the study inclusion and
additional imaging. The study was conducted according
to the Declaration of Helsinki and Good Clinical Prac-
tice guidelines and was approved by the local ethics
committee (ethics approval number 15/NS/0030).
MR imaging
MR imaging was performed using a 1.5 T whole-body
MR system (Ingenia; Philips, The Netherlands) with
dedicated anterior and posterior torso receiver coils. As
part of the clinical protocol, conventional LGE was
performed by acquiring a stack of short-axis and mul-
tiple long-axis views in each patient. These clinical LGE
images were acquired 10–15 min after intravenous injec-
tion of 0.2 mmol/kg gadobutrol (Gadovist; Bayer,
Germany) using a PSIR turbo field echo pulse sequence
(echo time (TE) 3.0 ms, repetition time (TR) 6.1 ms, flip
angle 25°, reference flip angle 5°, 19 lines acquired every
other RR-interval, linear profile order, field of view
350x350mm, slice thickness 10 mm, acquisition matrix
220 × 170, reconstructed voxel size 0.91 × 0.91 mm)
during the mid-diastolic resting period. All images were
acquired during repetitive 10–15 s breath-holds. A pre-
ceding Look-Locker sequence (TI scout) was performed
to determine the correct inversion time for viable myo-
cardium nulling.
In case participating patients showed ischemic myocar-
dial infarction in (one of) the acquired clinical images,
additional MR imaging was performed in a single slice
short-axis view showing the highest scar burden. A PSIR
turbo field echo pulse sequence (identical to the clinical
one described above) was performed twice with different
TIs set for LV blood nulling and viable myocardium nul-
ling in a randomized order for each patient. Both pulse se-
quences were performed during 10–15 s breath-holds. A
preceding Look-Locker sequence was performed for each
pulse sequence to determine up-to-date TIs for both LV
blood nulling as well as viable myocardium nulling. A
dedicated noise scan (identical pulse sequence without ex-
citation pulses) was performed afterwards to assess the
noise level. Additionally, in some patients a modified
Look-Locker inversion-recovery (MOLLI) T1-mapping
scan (3–5 scheme) was performed to determine T1 values
of the viable myocardium, LV blood, and scar tissue [9].
SNR and CNR measurements
For all acquired images, the manufacturer’s applied scaling
in the stored DICOM data was removed by converting the
data to floating point values as this reflects the true MR
signal range directly after reconstruction [10]. An expert
observer (AC) with >10 years of experience in cardiovas-
cular MRI then manually drew regions of interest (ROIs)
in the viable myocardium, LV blood pool, and scar tissue,
while blinded to patient and image type, using a custom-
made MATLAB (The Mathworks, Natick, MA, USA) soft-
ware tool. For each PSIR image, the observer was able to
set image contrast (window level and window width) as
preferred, while the image intensity histogram was shown.
Finally, the outer border of the entire LV was delineated.
Within each of the three tissue ROIs in each PSIR
image, the mean signal intensity was calculated as a
measure of the signal level. The entire LV ROI was then
projected onto the noise scan image. Within this ROI,
the standard deviation of the noise signal intensity was
A B
C D
Fig. 1 Phase-sensitive inversion-recovery (PSIR) and magnitude IR late gadolinium enhancement (LGE) images with viable myocardium nulling
and blood nulling. Routine viable myocardium nulling is shown in a & b, while the proposed left ventricular (LV) blood nulling is shown in c & d. The viable
myocardium, LV blood, and scar tissue are indicated by a ■, ♦, and •, respectively. Note that the nulled viable myocardium appears black using magnitude IR
(in b), whereas it appears dark gray using PSIR (in a). The corresponding gray scale bars for magnitude IR and PSIR are shown on the right of each image
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calculated as a measure of the LV noise level. This meas-
ure was used for both PSIR images in each patient, as
noise was not expected to vary at different inversion
times. In each PSIR image, the signal-to-noise ratio
(SNR) in the three tissues of interest was calculated by
dividing the tissue’s signal level by the LV noise level.
Contrast-to-noise ratios (CNRs) between all three tissues
were calculated, for both LV blood nulling as well as vi-
able myocardium nulling, by subtracting the SNRs of
two corresponding tissues.
Expert analysis
The same expert observer also 1) estimated the max-
imum scar transmurality, 2) assigned a confidence score
for scar detection and maximum transmurality, 3) traced
the scar border to accurately assess scar size, and 4) in-
dicated the circumferential endpoints of the scar to cal-
culate the angle over which the scar was present. First,
maximum scar transmurality was estimated using a 5-
point scale, as follows: 1 = 0%–20%, 2 = 21%–40%,
3 = 41%–60%, 4 = 61%–80%, and 5 = 81%–100%. Sec-
ond, confidence in scar detection and maximum trans-
murality was scored using a 4-point Likert scale, as
follows: 1 = non-diagnostic, 2 = low, 3 = medium,
4 = high. Third, scar size was assessed as the total num-
ber of voxels within each traced scar area. Differences in
scar size (between the two nulling times) were normal-
ized using the scar size acquired with viable myocardium
nulling. Enhancement of the papillary muscle was not
included in this analysis. Finally, the circumferential
angle of the present scar was calculated by indicating
the LV centre point, as well as both circumferential scar
endpoints in the myocardial wall.
Statistical analysis
The calculated CNRs in the PSIR images acquired at vi-
able myocardium nulling were compared to those ac-
quired at LV blood nulling. Paired-sample t-tests were
used to test for significant differences in CNR at the two
different nulling times. For the expert analyses, Wil-
coxon signed-rank tests were used to test for significant
differences in maximum transmurality and confidence
scores, while a one-sample t-test was used to test for sig-
nificant differences in normalized scar size. A paired-
sample t-test was used to test for significant differences
in circumferential scar angle. For the paired-sample t-
tests and one-sample t-test, normality of the data was
confirmed by using Shapiro-Wilk tests. P-values <0.05
were considered significant.
Simulations
Bloch simulations were performed in MATLAB to simu-
late the magnetization levels of the viable myocardium,
LV blood, and scar tissue, over multiple heartbeats. The
simulations included all sequence parameters and pulse
sequence details, such as start-up echoes, flip angle
sweeps, transverse signal spoiling, and image and PSIR
reference acquisitions. The relaxation times of the viable
myocardium, LV blood, and scar tissue, were determined
using the acquired T1 maps. Other relevant patient spe-
cific model parameters, such as heart rate, trigger delay,
and inversion times, were based on the actual scan
parameters.
Results
Study population
Of all patients who provided written informed consent,
nine male patients (63 ± 11y) showed ischemic myocar-
dial scar and underwent additional imaging. Imaging at
both inversion times, LV blood nulling and viable myo-
cardium nulling, was successfully performed at
22 ± 4.6 min and 23 ± 6.2 min post-injection, respect-
ively (Fig. 2). These post-injection times were not signifi-
cantly different (p = 0.220). The inversion times used for
LV blood nulling and viable myocardium nulling were
168 ± 28 ms and 259 ± 25 ms, respectively.
SNR and CNR measurements
The average scar-to-blood CNR in the PSIR images was
significantly increased (p < 0.001) by 99% to 8.78 when
nulling LV blood magnetization instead of viable myo-
cardium (Fig. 3). A significant mean difference of +4.37
(95% CI [+2.53, +6.22]) was observed in scar-to-blood
CNR when nulling LV blood magnetization. This in-
crease in scar-to-blood CNR was observed in all patients
regardless of which nulling time was used first (Fig. 4).
Despite the significant increase in scar-to-blood CNR
when nulling LV blood, a significant change in average
scar-to-myocardium CNR was not detected (p = 0.150).
The average blood-to-myocardium CNR, however, was
significantly decreased (p < 0.001) by 34% when nulling
LV blood. The measured SNRs for viable myocardium,
LV blood, and scar, for both myocardium nulling and LV
blood nulling, can be found in Table 1. The elapsed
times after contrast agent administration and used inver-
sion times are also illustrated here, as well as measured
T1 values for the three tissues of interest.
Expert analysis
No significant difference in maximum scar transmurality
was detected between LV blood nulling and viable myo-
cardium nulling (p = 0.317). In three patients, higher
maximum scar transmurality was observed when nulling
LV blood, while this was only the case in one patient
when nulling viable myocardium (Fig. 5a). All observed
differences were less than 20%. LV blood nulling, how-
ever, did lead to significantly higher confidence scores
(p = 0.038) compared to nulling viable myocardium. The
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maximum confidence score of 4 (=high) was assigned to
all patients when nulling LV blood, while only four pa-
tients received this score when viable myocardium was
nulled (Fig. 5b). None of the PSIR images, regardless of
nulling time, were assigned with non-diagnostic confi-
dence. No significant difference in normalized scar size
was detected between LV blood nulling and viable myo-
cardium nulling (p = 0.054). However, in seven patients
a larger scar area was observed when nulling LV blood
(Fig. 5c). In five of these patients, the observed scar size
was more than 40% larger when nulling LV blood com-
pared to nulling viable myocardium. In all these cases a
higher confidence score was assigned to LV blood nul-
ling. Finally, no significant difference in circumferential
scar angle was detected between LV blood nulling and
viable myocardium nulling (p = 0.117). On average, the
circumferential scar angle was 12 degrees larger when
nulling LV blood (Fig. 5d). Differences in scar angle
ranged from −14 to +46 degrees when nulling blood
compared to viable myocardium.
Simulations
Bloch simulations of the magnetization levels confirmed
the near-perfect nulling of both LV blood as well as viable
myocardium when using the corresponding pulse sequence
and tissue parameters (Fig. 6). The simulations also illus-
trated the magnetization evolution in the approach to the
steady state during acquisition. These approaches are differ-
ently shaped for viable myocardium nulling and LV blood
nulling, and therefore contributing to the observed contrast
differences. These different shapes are caused by the fact
that even though the time between the excitation pulses in
the acquisition shot (=TR) is the same for both nulling
times, magnetization recovery within each TR is faster
when the TI is set for blood nulling as the magnetization is
further away from the equilibrium value.
Discussion
Accurate subendocardial scar assessment in patients with
myocardial infarction is crucial as current treatment
Fig. 2 Phase-sensitive inversion-recovery (PSIR) late gadolinium enhancement (LGE) images in three myocardial infarction patients with ischemic scar. These
images are acquired with routine viable myocardium nulling (top row) and proposed left ventricular (LV) blood nulling (bottom row). Note that all images are
windowed so that viable myocardium appears homogeneously black. The arrows indicate the circumferential borders of the LV scar tissue
Fig. 3 Mean contrast-to-noise ratios (CNRs) between the viable
myocardium, left ventricular (LV) blood, and scar tissue. The CNRs
are shown for both LV blood nulling and viable myocardium nulling.
Error bars indicate the standard error of the mean. * = p < 0.001
Fig. 4 Scar-to-blood contrast-to-noise ratios (CNRs) with their
associated elapsed time after contrast agent (CA) injection. The dots
indicate ventricular (LV) blood nulling, while the triangles indicate
viable myocardium nulling. For each subject, a straight line
connects the two observations. Note that a dotted line indicates that
viable myocardium nulling was performed first, while a solid line
indicated that LV blood nulling was performed first
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strategies are based on this assessment and even tiny re-
gions of myocardial scar may already have great impact on
patient prognosis. Conventional LGE using viable myocar-
dium magnetization nulling is not always able to detect
these tiny regions of scar as the LV blood often has similar
signal intensity. Lowering the LV blood signal may be
achieved by using additional magnetization preparation
before or after the 180° inversion pulse. Multiple types of
additional magnetization preparation have recently been
proposed, including T2 preparation, magnetization transfer,
T1 rho using spin locking, and double and triple inversion
recovery [11–18]. All the above-mentioned magnetization
preparation schemes alter magnetization levels, thereby cre-
ating different types of contrast and possibly improving scar
Fig. 5 Expert analysis results for maximum scar transmurality (a), confidence score for scar detection and maximum transmurality (b), scar size (c), and
longitudinal scar angle (d). In all four subplots, the results are shown for each subject for both left ventricular (LV) blood nulling [diagonally striped /
green] and viable myocardium nulling [checkered / red]
Fig. 6 Bloch simulations of the (normalized) longitudinal magnetization (Mz). The Mz of viable myocardium [yellow], left ventricular (LV) blood
[orange], and myocardial scar [blue], are shown in a phase-sensitive inversion-recovery (PSIR) pulse sequence with LV blood nulling (a) and viable
myocardium nulling (b). For both subplots, the approach to the steady state during acquisition has been enlarged on the right to show the fine
pulse sequence details. The vertical black solid lines indicate the end of a heartbeat (HB), while the vertical red dotted lines indicate the acquisition of the
middle of k-space. Note that the time between the inversion pulse and the red dotted line, the inversion time, is significant shorter with LV blood
nulling (a) than with viable myocardium nulling (b)
Holtackers et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:64 Page 7 of 10
visibility. However, these magnetization preparations re-
quire extensive optimizations, additional training, and are
not available in routine clinical practice. Furthermore, spe-
cific energy absorption rate (SAR) levels are increased due
to the additional radiofrequency pulses.
In this study we presented a PSIR LGE method,
without using additional magnetization preparation,
which improves subendocardial scar conspicuity. Short-
ening the TI to the point of LV blood magnetization nul-
ling, in combination with PSIR reconstruction, led to a
significant increase in scar-to-blood contrast, while
maintaining excellent scar-to-myocardium contrast. Re-
gardless of whether normal viable myocardium nulling
or LV blood nulling was performed first, all subjects
showed increased scar-to-blood contrast with LV blood
nulling. As the washout of the contrast agent is faster in
the LV blood pool than in the infarct, scar-to-blood con-
trast is expected to naturally increase at later imaging
time points. However, even though myocardium nulling
was performed approximately 10 min later than LV
blood nulling in two subjects, scar-to-blood contrast still
remained higher with LV blood nulling. The significant
loss in blood-to-myocardium contrast does not interfere
with scar detection and analysis, as this contrast is only
used for anatomical visualisation of the viable myocar-
dium. Moreover, the observed blood-to-myocardium
contrast during LV blood nulling was still abundant.
Expert analysis showed that higher levels of confidence
were assigned to PSIR images acquired during LV blood
nulling compared to viable myocardium nulling. Espe-
cially in those patients with lower confidence scores dur-
ing viable myocardium nulling, large differences in scar
size and circumferential scar angle, up to 143% and 87%
respectively, were observed when nulling LV blood com-
pared to nulling viable myocardium. Although no signifi-
cant differences in maximum scar transmurality were
detected, expert confidence in the assessed transmurality
was similar or higher when LV blood was nulled, in all
patients. The assessed scar size was on average 44% lar-
ger when nulling LV blood, however this difference was
not significant (p = 0.054). However, we expect to detect
significant differences in scar size when a larger and
more diverse patient group is included. Moreover, these
images were reviewed by an expert operator with level
III accreditation and more than 10 years of experience.
The advantage of using dark-blood DE in less experi-
enced operators shall be assessed in future studies.
Simulations
Our Bloch simulations predict and confirm the nulling
of LV blood and viable myocardium when using corre-
sponding pulse sequence and tissue parameters. While
differences in steady state behaviour can partially explain
the effect on contrast changes, those are difficult to
predict precisely, as the observed contrast can depend on
numerous other variables such as contrast agent dosage,
elapsed time after contrast agent administration, and
clearance rate of the contrast agent. Blood velocity may
also play a role, even though non-selective IR pulses are
used [18]. Furthermore, additional effects, such as un-
known levels of off-resonance, magnetization transfer, and
insufficiently spoiled T2 magnetization, could play a role.
PSIR use in combination with LV blood nulling
In current clinical practice, wherein viable myocardium is
nulled on magnitude images, PSIR is mainly used to make
DE image quality less sensitive to the chosen TI, leading
to a reduction in image artefacts. However, the main fea-
ture of PSIR, which is retaining the sign of the signal in-
tensity, is then not fully exploited, as all magnetization
levels are either nulled or already positive. When image
acquisition is performed at shorter TIs, for example at LV
blood nulling, the main feature of PSIR is optimally
exploited resulting in perfect black myocardium, dark gray
LV blood at the null point, and bright scar. Already in
2002, Kellman et al. showed that scar size appearance was
significantly underestimated when using shorter TIs than
the nulling point of viable myocardium when using a trad-
itional magnitude image reconstruction [7]. In 2005, Set-
ser et al. also investigated scar size appearance with
conventional IR and found similar outcomes at TIs 50 ms
shorter than optimal myocardium nulling, however
showed that this underestimation was not observed when
using these shorter TIs in combination with PSIR [8]. We
found similar results in this study, justifying the use of
shorter inversion times in PSIR. In contrast to previous
studies, we aimed here explicitly for optimal LV blood
nulling, which was achieved at TIs that were on average
91 ms shorter than optimal viable myocardium nulling.
The breath-hold duration of the proposed PSIR sequence
with LV blood nulling is equal to the conventional PSIR se-
quence with viable myocardium nulling, as only the inver-
sion time is shortened. When conventional IR is used
instead of PSIR during routine clinical LGE, the breath-hold
duration will double to approximately 10–15 s as the 180°
inversion pulse is only applied every other heartbeat for
PSIR. However, since the PSIR allows additional relaxation
of the magnetization levels during the extra, second R-R
interval, increased signal levels are achieved resulting in
higher SNR. At the expense of this extra SNR, pulse se-
quence duration may be shortened using parallel imaging
methods, such as spatial sensitivity encoding, to compensate
for the extra scan time originally required for PSIR.
Limitations
All patients used in this study were already enrolled for
a clinical LGE examination, meaning that additional im-
aging for this study could only be performed afterwards.
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Therefore the study images were acquired between ap-
proximately 15–30 min post-injection. Even though this
is later than what would normally be done in routine
clinical care, it still remains within the 10–30 min post-
injection time window in which LGE is ideally per-
formed [19]. Acquisition of the study images started im-
mediately when the clinical protocol was finished, after
which the available radiologist directly reviewed the
quality of the earlier acquired clinical images. In two
subjects, additional clinical images needed to be ac-
quired that delayed the acquisition of one of the two
study images. This explains the large difference in
elapsed time after contrast administration between the
two acquisitions in these two subjects.
Two additional topics that require further discussion are
the possible effects of low flow regions near the LV endo-
cardium and possible distortions of the infarct edges due to
the presence of both positive and negative magnetization in
the same voxel. Low flow near the endocardium should not
have a significant effect on the observed signal, as the inver-
sion pulse is non-selective and thus should be flow inde-
pendent. In addition, as can be observed from our
simulations in Fig. 6, blood magnetization in the second
heartbeat is already fully recovered and close to the equilib-
rium magnetization before the acquisition of the reference
image. Since the blood magnetization is hardly affected by
the following low flip angle reference acquisition, the blood
magnetization again fully recovers before the next inversion
pulse is applied. As a result, regions of slow flow near the
LV border do not affect the signal here as they behave simi-
lar to the rest of the blood in the LV cavity.
Finally, when using PSIR with LV blood nulling, the TI
is set shorter compared to viable myocardium nulling.
Therefore the viable myocardium will have negative
magnetization while the infarct region already has posi-
tive magnetization. Voxels close to the edge of the in-
farcted region can therefore obtain both positive and
negative magnetization levels, possibly leading to
cancellation of the resulting magnetization in that voxel
and distorting the edge of the infarct. As this voxel be-
haves similarly to tissue that would be nulled, it appears
dark grey in a PSIR image. However, such a voxel would
also appear grey when using a conventional IR sequence
with viable myocardium nulling, as that voxel holds both
positive magnetization from the scar area (bright) and
nulled magnetization from the viable myocardium (black
in normal IR image). In both situations the scar border
appears greyish, which is a natural transition from the
bright scar area to the black viable myocardium.
Future perspectives
This study demonstrates the effect of using shorter TIs
in combination with PSIR during 2D LGE for the
detection of ischemic myocardial scar. However, the
proposed mechanism can also be applied in a free-
breathing 3D pulse sequence, offering new opportunities
for patients who are short of breath or who cannot cope
with long breath-hold durations. For future research,
additional studies are required that include a larger
number of patients with varying underlying causes of
(myocardial) scar. It is expected that significant differ-
ences in scar size and transmurality will be found when
using a larger and more diverse patient population. Mul-
tiple clinical experts should then be included in the ana-
lysis of the observed myocardial scar. Finally, automatic
detection and quantification of scar areas near the endo-
cardial border is likely to improve as a result of the in-
creased scar-to-blood contrast.
Conclusions
Nulling viable myocardium for PSIR LGE is a con-
tinuation of routine clinical practice from the time non-
phase-sensitive (magnitude) images were acquired with
LGE. For PSIR LGE, nulling the LV blood magnetization
instead significantly increases scar-to-blood contrast since
blood signal and scar signal no longer have similar levels.
We introduced a novel method that allows visualization of
contrast-enhanced tissues, while suppressing the blood,
and thereby improving subendocardial scar conspicuity in
PSIR LGE. As no additional magnetization preparation is
used, clinical application on current MR systems is readily
available without the need for extensive optimizations,
software modifications, and/or additional training.
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